Analyst consensus rating
Acurx Pharmaceuticals Analyst Rating: none
Direct answer
Acurx Pharmaceuticals's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.00.
Forecast evidence checked November 4, 2026.
Get free Acurx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.02
- Average price target
- $17.00
- High price target
- $31.00
- Low price target
- $10.00
- Low target gap
- +880.4%
- Target upside
- +1,566.7%
- High target gap
- +2,939.2%
- Target range width
- 2,058.8%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- November 4, 2026
- Valid through
- November 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Acurx Pharmaceuticals?
Acurx Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $17.00.
How far are Acurx Pharmaceuticals's low and high targets from the recorded price?
The low target implies +880.4%, while the high target implies +2,939.2%.
How many analysts are included in Acurx Pharmaceuticals's consensus?
The verified consensus includes 3 analysts.
How is Acurx Pharmaceuticals's target upside or downside calculated?
The average target of $17.00 is divided by the recorded price of $1.02, then one is subtracted to produce +1,566.7%. This does not guarantee a future return.
When was Acurx Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-04. The dataset is valid through 2026-11-11.